Thoracotomy

A major surgery in which the surgeon makes an incision through the chest wall, usually between the ribs, to reach the lungs, the pleura (the lining around the lungs), or other structures inside the chest. In asbestos-related disease, thoracotomy is used to take large tissue samples for diagnosis, to remove tumors, or to perform definitive operations such as pleurectomy/decortication (P/D) or extrapleural pneumonectomy (EPP) for mesothelioma.

Origin

The word combines the Greek thorax (chest) and tomē (a cutting). Open chest surgery developed rapidly in the early 20th century as anesthesia and positive-pressure ventilation made it possible to operate safely inside the chest cavity.

Significance in Asbestos Context

For patients with suspected or confirmed mesothelioma or asbestos-related lung cancer, thoracotomy is often the procedure that produces the definitive diagnosis and, in some cases, the main treatment. When smaller procedures such as a CT-guided needle biopsy or video-assisted thoracoscopic surgery (VATS) do not yield enough tissue, an open thoracotomy gives the pathologist a larger specimen for histologic subtyping (epithelioid, sarcomatoid, biphasic) and immunohistochemistry, details that directly shape treatment options and prognosis.

The operative report and pathology report generated from a thoracotomy are usually the single most important medical documents in an asbestos case. They establish the diagnosis, the tumor location and extent, and the tissue findings that experts rely on to link the disease to asbestos exposure. These same documents are typically required at the highest evidentiary tier of asbestos bankruptcy trust claims and are central to personal injury and wrongful death lawsuits, VA claims, and workers' compensation filings. The scope of the surgery, a limited diagnostic open biopsy versus a full P/D or EPP, also affects damages, because more extensive surgery generally means longer recovery, greater disability, and higher medical costs.

Example Sentence

After his VATS biopsy was inconclusive, the patient underwent a thoracotomy, and the resulting pathology report confirming epithelioid mesothelioma became the cornerstone of his lawsuit and trust fund claims.

Related Terms

Mesothelioma, Pleurectomy/Decortication (P/D), Extrapleural Pneumonectomy (EPP), Video-Assisted Thoracoscopic Surgery (VATS), Biopsy, Immunohistochemistry

Notes

• Request complete copies of the operative report, anesthesia record, and surgical pathology report, and ask the hospital pathology department to preserve the paraffin tissue blocks and slides. These are often needed for second-opinion review and for trust claims.
• If thoracotomy is recommended, ask your surgeon directly why VATS or a needle biopsy is not appropriate, what specific procedure is planned (diagnostic biopsy, P/D, or EPP), and what their personal volume is for that operation; outcomes improve substantially at high-volume mesothelioma centers.
• Plan for a hospital stay of roughly 5–10 days and a recovery of 6–12 weeks. Discuss pain control options before surgery, including epidural analgesia and intercostal nerve blocks, since post-thoracotomy pain can be severe and long-lasting.
• Keep a daily journal during recovery documenting pain levels, breathing limitations, fatigue, sleep disruption, and inability to perform normal activities; this contemporaneous record strengthens damages claims and helps your medical team manage symptoms.
• Before surgery, notify your attorney; the surgical specimen and operative findings may need to be coordinated with expert pathologists retained for your case to avoid the loss of irreplaceable evidence.